Prevention of radiolysis of monoclonal antibody during labeling

Journal of Nuclear Medicine

Volumn 37, Issue 8, 1996, Pages 1384-1388

  Chakrabarti, Munna C ^b   Le, Nhat ^b   Paik, Chang H ^b   De Graff, William G ^b   Carrasquillo, Jorge A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

immunoreactivity; labeling damage; monoclonal antibody; radioimmunotherapy; radiolysis; yttrium 90

Indexed keywords

ASCORBIC ACID; MONOCLONAL ANTIBODY; YTTRIUM 90;

ARTICLE; DOSE RESPONSE; IMMUNOREACTIVITY; IRRADIATION; ISOTOPE LABELING; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RADIOLYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ASCORBIC ACID; COBALT RADIOISOTOPES; CYSTEAMINE; GLYCEROL; HUMANS; IODINE RADIOISOTOPES; ISOTOPE LABELING; MICE; MICE, INBRED BALB C; RADIATION DOSAGE; RADIATION-PROTECTIVE AGENTS; RADIOIMMUNOTHERAPY; SERUM ALBUMIN; YTTRIUM RADIOISOTOPES;

EID: 0029738879     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Carrasquillo JA. Radioimmunoscintigraphy with polyclonal or monoclonal antibodies. In: Zalutsky MR, ed. Antibodies in radioligands and therapy. Boca Raton, FL: CRC Press; 1989;169-198.
2. Press OW, Eary JF, Appelbaum FR, et al. Radiolabeled antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med 1993;32:1219-1224.
3. 131I] anti-B1 (anti-CD20) antibody. N Engl J Med 1993;329:459-465.
4. Vriesendorp HM, Herpst JM, Germack MA, et al. Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation therapy oncology group 87-01. J Clin Oncol 1991;9:918-928. [Erratum, J Clin Oncol 1991;9:1516.]
5. Mausner LF, Srivastava SC. Selection of radionuclides for radioimmunotherapy. Med Phys 1993;20:503-509.
6. Ferens JM, Krohn KA, Beaumier PL, et al. High-level iodination of monoclonal antibody fragments for radiotherapy. J Nucl Med 1984;25:376-370.
7. Kishore R, Eary J, Krohn KA, et al. Autoradiolysis of iodinated monoclonal antibody preparations. Nucl Med Biol 1986;13:457-459.
8. Pizzarello DJ. Direct and indirect action. In: Pizzarello DJ, Witcofski RL, eds. Basic radiation biology, 2nd ed. Philadelphia: Lea & Febiger;1975:20-29.
9. Reynolds JC, Maloney P, Rotman M, et al. Radiohalogenation of monoclonal antibody: Experiences with radioiodination of monoclonal antibodies for radioimmunotherapy. In: Srivastava SC, ed. Radiolabeled monoclonal antibodies for imaging and therapy. Plenum; 1988:215-227.
10. Wahl RL, Wissing J, Rosario RD, Zasadny KR, et al. Inhibition of autoradiolysis of radiolabeled monoclonal antibodies by cryopreservation. J Nucl Med 1990;31:84-89.
11. Royston I, Majda JA, Baird SM, Meserve BL, Griffiths JC. Human T-cell antigens defined by monoclonal antibodies: the 65,000 dalton antigen of T-cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin. J Immunol 1980;125:725-731.
12. Hunter WA, Greenwood FC. Preparation of iodine-131-labeled human growth hormone of high specific activity. Nature 1962;194:495-496.
13. 125I radiolabeled T101 anti-CD5 monoclonal antibody. Nucl Med Biol 1990;17: 201-207.
14. Lindmo T, Boven E, Cuttitta F, Fedorko J, Bunn PA. Determination of the immunoreactive fraction of radiolabeled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J Immunol Method 1984;72:77-89.
15. Hnatowich DJ, Virzi F, Doherty PW. DTPA-coupled antibodies labeled with yttrium-90. J Nucl Med 1985;26:503-509.
16. Loevinger R, Berman M. A revised schema for calculating the absorbed dose from biologically distributed radionuclides. MIRD pamphlet no. I, revised. New York: Society of Nuclear Medicine, 1976.
17. Prestwich WV, Nunes J, Kowk CS. Beta dose point kernels for radionuclides of potential use in radioimmunotherapy. J Nucl Med 1989;30:1036-1046.
18. Siegel JA, Stabin MG. Absorbed fractions for electrons and beta particles in spheres of various sizes. J Nucl Med 1994;35:152-156.
19. 90Y radioimmunotherapy. Bioconj Chem 1991;12:187-194.
20. Hnatowich DJ, Virzi F, Winnard P, Fogarasi M, Rusckowski M. Investigations of ascorbate for direct labeling of antibodies with technetium-99m. J Nucl Med 1994;35: 127-134.
21. Larson SM. A tentative biological model for the localization of radiolabeled antibody in tumor: the importance of immunoreactivity. Nucl Med Biol 1986;13:393-399.